Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...

Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...

Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.

Elevance Health (ELV) stock rises as CFO cites underestimated Q1 profit forecasts from analysts for the company at Barclays ...

We recently compiled a list of the Top 10 Health Insurance Stocks To Buy. In this article, we are going to take a look at ...

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...

Elevance Health (ELV) shares soared 3.1% in the last trading session to close at $422.04. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

In its fourth quarter 2024 investor letter, GreensKeeper Asset Management emphasized stocks such as Elevance Health, Inc. (NYSE:ELV) in the fourth quarter 2024 investor letter. Elevance Health ...

Many stock analysts see Indianapolis-based Elevance’s recent struggles as an opportunity. Thirteen of 24 analysts tracked by The Wall Street Journal rate the health insurer as a buy.

Shares of Elevance Health Inc. ELV shed 2.61% to $411.04 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.49% to 5,599.30 ...

The board of Elevance Health, Inc. (NYSE:ELV) has announced that it will be paying its dividend of $1.71 on the 25th of March, an increased payment from last year's comparable dividend.